Protalix BioTherapeutics (PLX) Reports Q2 Loss of $0.16

Go back to Protalix BioTherapeutics (PLX) Reports Q2 Loss of $0.16
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.16 --0 (-0%)
Previous Close $2.16    52 Week High $1.11 
Open $2.16    52 Week Low $0.41 
Day High $2.16    P/E N/A 
Day Low $2.16    EPS $-0.29 
Volume 616